If you're taking a GLP-1 medication and experience any of the following, it's crucial to seek medical attention promptly: While the potential for gallbladder issues might sound concerning, it shouldn't deter you from considering GLP-1s if they are recommended by your healthcare provider
Semaglutide as an active ingredient is FDA-approved under the brand names Ozempic (for type 2 diabetes) and Wegovy (for weight management)
4 reported observational data from Shanghai Sixth Peoples Hospital, China, showing that, with adequate treatment duration, GLP-1 agonists may have disease-modifying effects in patients with KOA with comorbid Type 2 diabetes, potentially mediated by weight loss
If symptoms persist beyond 8 weeks at a stable dose, clinical evaluation is important to exclude other causes (infection, dietary intolerance, concurrent medications)
Next Steps: Take the free assessment quiz to check your eligibility for a personalized program
The next status conference is set for February 24